N-Ethylhexedrone was patented from the German pharmaceutical organization Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1]It is actually strongly encouraged that a person use harm reduction practices when applying this drug. Tolerance and addiction